A recent study showed that although the IL-10 serum levels are comparable in AD patients and healthy controls, the frequency of CD4+ T-cells expressing IL-10 in AD group is much higher than that in controls, indication a systemic effort to counterbalance the pro-inflammatory responses in the AD brain (Torres et al., 2013). The gene discussed is IL10; the disease is Alzheimer disease.